(Q35979363)

11 August 2017

1 reference

title

Hormones, menopause, and heart disease: making sense of the Women's Health Initiative (English)

1 reference

11 August 2017

Paula S Derry

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

11 August 2017

published in

Women's Health Issues

1 reference

11 August 2017

volume

14

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

212-219

1 reference

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Postmenopausal estrogen and prevention bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Hormone replacement therapy, heart disease, and other considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Hormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Uneasy alliance--clinical investigators and the pharmaceutical industry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Why do professionals disagree? The case of hormone replacement therapy and coronary heart disease prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Failure of estrogen plus progestin therapy for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Estrogen plus progestin and the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Coronary heart disease in women--an ounce of prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WHI.2004.07.004

10.1016/J.WHI.2004.07.004

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference